NICOLE TAYLOR: Open Payments
NPI 1174987432 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,213 in 59 payments from 12 companies in 2025. Trend: 2023 $114 · 2024 $0 · 2025 $1,213
Food & beverage: $1,213
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $273 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $196 |
| Janssen Pharmaceuticals, Inc | 5 | $152 |
| Otsuka America Pharmaceutical, Inc. | 7 | $133 |
| Teva Pharmaceuticals USA, Inc. | 4 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $85 |
| Alkermes, Inc. | 3 | $79 |
| Neurocrine BioSciences, Inc. | 3 | $60 |
| Axsome Therapeutics, Inc. | 3 | $58 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
Products named: VRAYLAR, CAPLYTA, REXULTI, SPRAVATO, TRINTELLIX, ARISTADA, INGREZZA, INVEGA SUSTENNA.
Industry payments across NY — which companies pay providers there.
